Clinical proteomics of myeloid leukemia

Myeloid leukemias are a heterogeneous group of diseases originating from bone marrow myeloid progenitor cells. Patients with myeloid leukemias can achieve long-term survival through targeted therapy, cure after intensive chemotherapy or short-term survival because of highly chemoresistant disease. T...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hjelle, Sigrun M, Forthun, Rakel B, Haaland, Ingvild, Reikvam, Håkon, Sjøholt, Gry, Bruserud, Øystein, Gjertsen, Bjørn T
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2010
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2905101/
https://ncbi.nlm.nih.gov/pubmed/20587003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm162
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items